Helicobacter pylori Infection: Therapy Changes and Challenges
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotic Therapy in Infectious Diseases".
Deadline for manuscript submissions: closed (15 November 2022) | Viewed by 10305
Special Issue Editor
2. College of Medicine, Chang Gung University, Taoyuan, Taiwan
3. Chang Gung Microbiota Therapy Center, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan
Interests: peptic ulcer disease; gastric cancer; inflammatory bowel disease; Helicobacter pylori
Special Issue Information
Dear Colleagues,
Helicobacter pylori is a well-known pathogen associated with several upper gastrointestinal tract diseases, including peptic ulcer disease, atrophic gastritis, and gastric malignancies. The possible causes for eradication therapy failures include antibiotic resistance, smoking, high bacterial load before treatment, bacterial genotype, and polymorphisms of metabolism of PPIs. The successful rate of eradication of H. pylori has recently declined, mainly due to the increasing prevalence of drug resistance. With the changing profile of H. pylori antibiotic resistance, optimizing the therapy for H. pylori infection has become challenging.
Dr. Chia-Jung Kuo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- H. pylori infection
- antibiotic resistance
- multi-drug resistance
- precision medicine
- eradication
- first-line
- rescue
- susceptibility test
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.